KEX-02

N/A

Report date: 2024/12/20 15:03:26

Base Information

Drug NameKEX-02
Drug Alias NameLactobacillus Bifidobacterium V9 (Shenzhen Juntuo Biotechnology Co Ltd)KEX-02V9Kex02Kex-02
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaClinical
Originator CompaniesShenzhen Juntuo Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangxi Provincial Cancer HospitalShenzhen Juntuo Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A